• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Simona Soverini, Andreas Hochhaus, +11 authors Giovanni Martinelli
  • Medicine
  • Blood
  • 2011 (First Publication: 4 August 2011)
  • Mutations in the Bcr-Abl kinase domain may cause, or contribute to, resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia patients. Recommendations aimed to rationalize the useExpand
  • Dietger Niederwieser, Michael Maris, +15 authors Rainer F Storb
  • Medicine
  • Blood
  • 2003 (First Publication: 15 February 2003)
  • Toxicities of high-dose conditioning regimens have limited the use of conventional unrelated donor hematopoietic cell transplantation (HCT) to younger, medically fit patients. Based on preclinicalExpand
  • Stephanie G. Willis, Thoralf Lange, +9 authors Michael W. Deininger
  • Medicine, Biology
  • Blood
  • 2005 (First Publication: 15 September 2005)
  • Mutations in the kinase domain (KD) of BCR-ABL are the leading cause of acquired imatinib resistance. In some cases, identical mutations were detected at relapse and in pretherapeutic specimens,Expand
  • Boglarka Gyurkocza, Rainer F Storb, +17 authors Brenda M Sandmaier
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2010 (First Publication: 10 June 2010)
  • PURPOSE Allogeneic hematopoietic cell transplantation (HCT) after high-dose conditioning regimens imposes prohibitively high risks of morbidity and mortality for patients with high-risk acute myeloidExpand
  • Andrew R. Rezvani, Barry E Storer, +13 authors David G Maloney
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2008 (First Publication: 10 January 2008)
  • PURPOSE Few effective treatment options exist for chemotherapy-refractory indolent or transformed non-Hodgkin's lymphoma (NHL). We examined the outcome of nonmyeloablative allogeneic hematopoieticExpand
  • Ute Hegenbart, Dietger Niederwieser, +17 authors Rainer Storb
  • Medicine
  • 2006 (First Publication: 20 January 2006)
  • Purpose The use of low-dose, irradiation-based preparative regimens have allowed the extension of allografting to older and medically infirm patients. The study reported here assessed outcomes forExpand
  • Ginna G. Laport, Brenda M Sandmaier, +17 authors Rainer F Storb
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2008 (First Publication: 1 February 2008)
  • Allogeneic hematopoietic cell transplantation (HCT) is the only curative strategy for patients with myelodysplastic syndrome (MDS) and myeloproliferative disorders (MPD). We report the results of 148Expand
  • Jacqueline Maier, Thoralf Lange, +8 authors Nikolas von Bubnoff
  • Biology, Medicine
  • Clinical Cancer Research
  • 2013 (First Publication: 5 July 2013)
  • Purpose: In gastrointestinal stromal tumor (GIST), there is no biomarker available that indicates success or failure of therapy. We hypothesized that tumor-specific v-kit Hardy-Zuckerman 4 felineExpand